Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 Jul 2017
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms LOTUS
- Sponsors Takeda
- 04 Jul 2017 Planned primary completion date changed from 30 Aug 2017 to 31 Aug 2017.
- 04 Jul 2017 Planned number of patients changed from 50 to 53.
- 04 Jul 2017 Status changed from recruiting to active, no longer recruiting.